Here's Why Mankind Pharma (NSE:MANKIND) Has Caught The Eye Of Investors
May 11
Have your own idea? Try our Stock Screener
Indian (NIFTY) Pharma Industry Analysis
UpdatedMay 16, 2025
DataAggregated Company Financials
Companies170
- 7D2.7%
- 3M5.1%
- 1Y13.9%
- YTDn/a
The Pharma is pretty flat in the last 7 days, but Mankind Pharma has stood out, gaining 5.0%. As for the the longer term, the industry is up 14% over the past 12 months. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Indian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 16 May 2025 | ₹19.7t | ₹3.9t | ₹575.1b | 31x | 34.2x | 5x |
| Sun, 13 Apr 2025 | ₹19.7t | ₹3.9t | ₹559.2b | 27.6x | 35.2x | 5.1x |
| Tue, 11 Mar 2025 | ₹18.5t | ₹3.9t | ₹559.4b | 27.2x | 33.1x | 4.8x |
| Thu, 06 Feb 2025 | ₹20.0t | ₹3.9t | ₹543.7b | 31.6x | 36.8x | 5.2x |
| Sat, 04 Jan 2025 | ₹21.3t | ₹3.8t | ₹527.0b | 36.3x | 40.5x | 5.6x |
| Mon, 02 Dec 2024 | ₹20.7t | ₹3.8t | ₹526.7b | 34.1x | 39.3x | 5.4x |
| Wed, 30 Oct 2024 | ₹19.6t | ₹3.5t | ₹446.7b | 38.5x | 44x | 5.7x |
| Fri, 27 Sep 2024 | ₹21.5t | ₹3.7t | ₹492.6b | 40.6x | 43.7x | 5.8x |
| Sun, 25 Aug 2024 | ₹20.7t | ₹3.7t | ₹492.4b | 37.7x | 42.1x | 5.6x |
| Tue, 23 Jul 2024 | ₹18.7t | ₹3.6t | ₹454.7b | 34.3x | 41x | 5.2x |
| Thu, 20 Jun 2024 | ₹17.5t | ₹3.6t | ₹448.3b | 32.6x | 39.1x | 4.9x |
| Sat, 18 May 2024 | ₹17.1t | ₹3.5t | ₹435.0b | 34.9x | 39.2x | 4.9x |
| Mon, 15 Apr 2024 | ₹16.8t | ₹3.5t | ₹418.9b | 32.7x | 40.2x | 4.8x |
| Wed, 13 Mar 2024 | ₹16.8t | ₹3.5t | ₹418.7b | 32x | 40.1x | 4.8x |
| Fri, 09 Feb 2024 | ₹16.7t | ₹3.4t | ₹417.4b | 34.1x | 40x | 4.9x |
| Sun, 07 Jan 2024 | ₹15.5t | ₹3.4t | ₹395.9b | 34.8x | 39.3x | 4.6x |
| Tue, 05 Dec 2023 | ₹14.3t | ₹3.4t | ₹395.1b | 31.4x | 36.2x | 4.2x |
| Thu, 02 Nov 2023 | ₹12.9t | ₹3.3t | ₹376.9b | 29x | 34.3x | 3.9x |
| Sat, 30 Sep 2023 | ₹13.3t | ₹3.3t | ₹369.5b | 30x | 35.9x | 4.1x |
| Mon, 28 Aug 2023 | ₹12.8t | ₹3.3t | ₹367.0b | 29.1x | 35x | 3.9x |
| Wed, 26 Jul 2023 | ₹12.3t | ₹3.2t | ₹342.7b | 26.1x | 36x | 3.9x |
| Fri, 23 Jun 2023 | ₹11.4t | ₹3.2t | ₹342.4b | 26.2x | 33.4x | 3.6x |
| Sun, 21 May 2023 | ₹10.3t | ₹3.1t | ₹302.1b | 26.8x | 33.9x | 3.3x |
| Tue, 18 Apr 2023 | ₹9.8t | ₹3.0t | ₹277.7b | 25.6x | 35.4x | 3.3x |
| Thu, 16 Mar 2023 | ₹9.3t | ₹3.0t | ₹277.5b | 23.1x | 33.4x | 3.1x |
| Sat, 11 Feb 2023 | ₹9.8t | ₹3.0t | ₹279.3b | 24.9x | 35x | 3.3x |
| Mon, 09 Jan 2023 | ₹9.9t | ₹2.9t | ₹274.9b | 26.8x | 36x | 3.5x |
| Wed, 07 Dec 2022 | ₹10.1t | ₹2.9t | ₹274.9b | 26.8x | 36.9x | 3.5x |
| Fri, 04 Nov 2022 | ₹10.5t | ₹2.8t | ₹262.7b | 24.3x | 40.1x | 3.8x |
| Sun, 02 Oct 2022 | ₹9.9t | ₹2.8t | ₹261.9b | 23.5x | 37.7x | 3.5x |
| Tue, 30 Aug 2022 | ₹9.6t | ₹2.8t | ₹261.9b | 23.5x | 36.8x | 3.5x |
| Thu, 28 Jul 2022 | ₹9.6t | ₹2.8t | ₹273.0b | 21.1x | 35.2x | 3.5x |
| Sat, 25 Jun 2022 | ₹9.1t | ₹2.8t | ₹273.8b | 20.7x | 33.4x | 3.3x |
| Mon, 23 May 2022 | ₹9.7t | ₹2.7t | ₹318.1b | 21.5x | 30.4x | 3.6x |
Price to Earnings Ratio
30.4x
Current Industry PE
- Investors are relatively neutral on the Indian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 37.1x.
- The 3-year average PS ratio of 4.3x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 21% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Pharma compare with similar industries?
| IN Market | 5.04% | |
| Healthcare | 3.13% | |
| Pharma | 2.69% | |
| Pharma | 2.69% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MANKIND Mankind Pharma | ₹2.57k | 6.8% +₹67.9b | 23.1% | PE52x | |
| 500124 Dr. Reddy's Laboratories | ₹1.23k | 6.4% +₹61.7b | 6.1% | PE18.1x | |
| 500420 Torrent Pharmaceuticals | ₹3.26k | 4.0% +₹43.0b | 21.0% | PE59.3x | |
| ALKEM Alkem Laboratories | ₹5.22k | 5.5% +₹32.8b | -4.0% | PE29x | |
| ZYDUSLIFE Zydus Lifesciences | ₹902.70 | 2.7% +₹24.2b | -14.1% | PE20x |
